MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: Secondary analyses of the Imagine-RA trial

Signe Kaas Møller-Bisgaard; K Horslev-Petersen; B Ejbjerg; Merete Lund Hetland; R Christensen; Lykke Midtbøll Ørnbjerg; Daniel Erik Glinatsi; JM Moller; M Boesen; K Stengaard-Pedersen; Ole Rintek Madsen; B Jensen; J Villadsen; EM Hauge; P Bennett; O Hendricks; K Asmussen; M Kowalski; HM Lindegaard; H Bliddal; NS Krogh; T Ellingsen; A Nielsen; AG Jurik; L Balding; H Thomsen; Mikkel Østergaard

MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: Secondary analyses of the Imagine-RA trial

Signe Kaas Møller-Bisgaard, K Horslev-Petersen, B Ejbjerg, Merete Lund Hetland, R Christensen, Lykke Midtbøll Ørnbjerg, Daniel Erik Glinatsi, JM Moller, M Boesen, K Stengaard-Pedersen, Ole Rintek Madsen, B Jensen, J Villadsen, EM Hauge, P Bennett, O Hendricks, K Asmussen, M Kowalski, HM Lindegaard, H BliddalNS Krogh, T Ellingsen, A Nielsen, AG Jurik, L Balding, H Thomsen, Mikkel Østergaard

Department for Rheumatology and Spine Diseases

Original language	Danish
Article number	FRI0019
Journal	Annals of the Rheumatic Diseases
Volume	79
Issue number	Suppl. 1
Pages (from-to)	581-582
Number of pages	2
ISSN	0003-4967
Publication status	Published - 2020

Cite this

Møller-Bisgaard, S. K., Horslev-Petersen, K., Ejbjerg, B., Hetland, M. L., Christensen, R., Ørnbjerg, L. M., Glinatsi, D. E., Moller, JM., Boesen, M., Stengaard-Pedersen, K., Madsen, O. R., Jensen, B., Villadsen, J., Hauge, EM., Bennett, P., Hendricks, O., Asmussen, K., Kowalski, M., Lindegaard, HM., ... Østergaard, M. (2020). MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: Secondary analyses of the Imagine-RA trial. Annals of the Rheumatic Diseases, 79(Suppl. 1), 581-582. Article FRI0019.

MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: Secondary analyses of the Imagine-RA trial. / Møller-Bisgaard, Signe Kaas; Horslev-Petersen, K; Ejbjerg, B et al.
In: Annals of the Rheumatic Diseases, Vol. 79, No. Suppl. 1, FRI0019, 2020, p. 581-582.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Møller-Bisgaard, SK, Horslev-Petersen, K, Ejbjerg, B, Hetland, ML, Christensen, R, Ørnbjerg, LM , Glinatsi, DE, Moller, JM, Boesen, M, Stengaard-Pedersen, K, Madsen, OR, Jensen, B, Villadsen, J, Hauge, EM, Bennett, P, Hendricks, O, Asmussen, K, Kowalski, M, Lindegaard, HM, Bliddal, H, Krogh, NS, Ellingsen, T, Nielsen, A, Jurik, AG, Balding, L, Thomsen, H & Østergaard, M 2020, 'MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: Secondary analyses of the Imagine-RA trial', Annals of the Rheumatic Diseases, vol. 79, no. Suppl. 1, FRI0019, pp. 581-582.

Møller-Bisgaard SK, Horslev-Petersen K, Ejbjerg B, Hetland ML, Christensen R, Ørnbjerg LM et al. MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: Secondary analyses of the Imagine-RA trial. Annals of the Rheumatic Diseases. 2020;79(Suppl. 1):581-582. FRI0019.

Møller-Bisgaard, Signe Kaas ; Horslev-Petersen, K ; Ejbjerg, B et al. / MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: Secondary analyses of the Imagine-RA trial. In: Annals of the Rheumatic Diseases. 2020 ; Vol. 79, No. Suppl. 1. pp. 581-582.

@article{dece91d4bff14991a34d67c4f5965913,

title = "MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: Secondary analyses of the Imagine-RA trial",

author = "M{\o}ller-Bisgaard, {Signe Kaas} and K Horslev-Petersen and B Ejbjerg and Hetland, {Merete Lund} and R Christensen and {\O}rnbjerg, {Lykke Midtb{\o}ll} and Glinatsi, {Daniel Erik} and JM Moller and M Boesen and K Stengaard-Pedersen and Madsen, {Ole Rintek} and B Jensen and J Villadsen and EM Hauge and P Bennett and O Hendricks and K Asmussen and M Kowalski and HM Lindegaard and H Bliddal and NS Krogh and T Ellingsen and A Nielsen and AG Jurik and L Balding and H Thomsen and Mikkel {\O}stergaard",

note = "COPECARE",

year = "2020",

language = "Dansk",

volume = "79",

pages = "581--582",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 1",

}

TY - ABST

T1 - MRI inflammation, disease activity and functional impairment are more effectively reduced by escalation to biologics compared to CSDMARD-escalation in rheumatoid arthritis patients in clinical remission following a treat-to-target strategy: Secondary analyses of the Imagine-RA trial

AU - Møller-Bisgaard, Signe Kaas

AU - Horslev-Petersen, K

AU - Ejbjerg, B

AU - Hetland, Merete Lund

AU - Christensen, R

AU - Ørnbjerg, Lykke Midtbøll

AU - Glinatsi, Daniel Erik

AU - Moller, JM

AU - Boesen, M

AU - Stengaard-Pedersen, K

AU - Madsen, Ole Rintek

AU - Jensen, B

AU - Villadsen, J

AU - Hauge, EM

AU - Bennett, P

AU - Hendricks, O

AU - Asmussen, K

AU - Kowalski, M

AU - Lindegaard, HM

AU - Bliddal, H

AU - Krogh, NS

AU - Ellingsen, T

AU - Nielsen, A

AU - Jurik, AG

AU - Balding, L

AU - Thomsen, H

AU - Østergaard, Mikkel

N1 - COPECARE

PY - 2020

Y1 - 2020

M3 - Konferenceabstrakt i tidsskrift

SN - 0003-4967

VL - 79

SP - 581

EP - 582

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 1

M1 - FRI0019

ER -